$Excess Toxicity Associated with Docetaxel and Irinotecan in Patients with Metastatic, Gemcitabine-Refractory Pancreatic Cancer: Results of a Phase II Study$

Excess Toxicity Associated with Docetaxel and Irinotecan in Patients with Metastatic, Gemcitabine-Refractory Pancreatic Cancer: Results of a Phase II Study

Ko, Andrew H.; Dito, Elizabeth; Schillinger, Brian; Venook, Alan P.; Bergsland, Emily K.; Tempero, Margaret A.

期刊名称Cancer Investigation
作者Ko, Andrew H.; Dito, Elizabeth; Schillinger, Brian; Venook, Alan P.; Bergsland, Emily K.; Tempero, Margaret A.
卷第26卷
期第1期
印刷ISSN0735-7907
电子ISSN1532-4192
文件大小139.38KB
发表时间2008-01
DOI10.1080/07357900701681483
页码47-52

发现好书期刊，享受阅读乐趣

Excess Toxicity Associated with Docetaxel and Irinotecan in Patients with Metastatic, Gemcitabine-Refractory Pancreatic Cancer: Results of a Phase II Study